Loading clinical trials...
Loading clinical trials...
Clinical Utility of a Non Endoscopic Device EsoCheck and Biomarker EsoGuard as Alternative to Endoscopy for Screening for Barrett's Esophagus in At Risk Population (ASBE) A Randomized Controlled, Virtual Patient Trial
Conditions
Interventions
EsoGuard result
Locations
1
United States
Lucid Diagnostics
New York, New York, United States
Start Date
April 12, 2023
Primary Completion Date
July 31, 2024
Completion Date
August 19, 2024
Last Updated
October 30, 2025
NCT04939051
NCT05753748
NCT06746623
NCT05056051
NCT03853772
NCT05706025
Lead Sponsor
Lucid Diagnostics, Inc.
Collaborators
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions